COVID-19 Vaccine Availability
Stopping the COVID-19 pandemic is going to take all our tools: vaccination, masking, washing hands and physical distancing.
Following CDC and state distribution guidance, Bon Secours is committed to providing access to the COVID-19 vaccines in the communities we serve.
Initially, vaccines will be available in a phased approach beginning with those at highest risk of exposure. As vaccines become more readily available, other groups will become eligible. As distribution varies from state-to-state, please visit our state specific page for more detailed information about vaccine distribution in your area.
We appreciate your patience as we work through the process of providing vaccines to those in our communities.
Visit your state’s Department of Health website for the latest information on COVID-19 vaccine availability where you live.
Upstate SC COVID-19 Vaccination Program
As part of the South Carolina DHEC vaccination plan, all Phase 1a workers must register or receive their first vaccine dose by Jan. 15, to ensure priority for the vaccine.
Virginia COVID-19 Vaccination Information
As we receive vaccine from the state, Bon Secours will schedule COVID-19 vaccination appointments for those identified in the State of Virginia’s Phase 1B for distribution.
Attestation for Administration of COVID-19 ...
Find the Attestation for Administration of COVID-19 Vaccine Per Emergency Use Authorization before your appointment.
COVID-19 Vaccine FAQs
Have questions about the COVID-19 vaccines and when you may be able to receive one?
Bon Secours pausing distribution of Janssen/Johnson and Johnson (J&J) vaccine following CDC and FDA recommendation
The Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC) have recommended a pause in the use of Janssen/J&J COVID-19 vaccine due to reports of six rare but serious blood clots following administration of the Janssen/J&J COVID-19 vaccine.
Bon Secours is following this recommendation and will not distribute any additional doses of the Janssen/J&J COVID-19 vaccine to patients at this time. Ensuring our patient’s health is key to everything we do, and that’s one of the reasons we are taking this recommendation seriously.
This recommendation shows the vaccine monitoring and early warning system in action. The FDA, CDC and health care providers across the nation are committed to ensuring COVID-19 vaccine safety. The Vaccine Adverse Event Reporting System (VAERS) is the early warning system used to monitor adverse events that happen after vaccination and enables quick detection of unusual or unexpected patterns of health problems.
Right now, these adverse events appear to be extremely rare. However, if you have received the Janssen/J&J vaccine and develop severe headache, abdominal pain, leg pain, or shortness of breath within three weeks after vaccination, contact your health care provider.
Bon Secours Monitoring Coronavirus (COVID-19)
Bon Secours continues to monitor and follow the latest novel coronavirus (COVID-19) guidelines from the Centers for Disease Control and Prevention (CDC). Find general COVID-19 information and resources.